Vir Biotechnology, Inc.
NASDAQ:VIR
7.15 (USD) • At close March 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 74.205 | 86.18 | 1,580.472 | 1,087.068 | 67.245 | 0.711 | 0.868 | 0.149 |
| Cost of Revenue
| 0.845 | 2.765 | 146.319 | 65.865 | 301.579 | 148.472 | 100.229 | 62.512 |
| Gross Profit
| 73.36 | 83.415 | 1,434.153 | 1,021.203 | -234.334 | -147.761 | -99.361 | -62.363 |
| Gross Profit Ratio
| 0.989 | 0.968 | 0.907 | 0.939 | -3.485 | -207.821 | -114.471 | -418.544 |
| Reseach & Development Expenses
| 506.499 | 589.671 | 474.648 | 448.006 | 302.411 | 148.472 | 100.229 | 62.512 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 70.937 | 37.598 | 29.131 | 21.693 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 119.031 | 174.049 | 161.762 | 160.793 | 70.937 | 37.598 | 29.131 | 21.693 |
| Other Expenses
| 34.995 | 0 | -35.325 | -8.347 | -9.123 | -7.38 | -0.212 | 0.083 |
| Operating Expenses
| 660.525 | 767.72 | 601.085 | 600.452 | 364.225 | 178.69 | 119.56 | 81.646 |
| Operating Income
| -587.165 | -684.305 | 833.068 | 276.891 | -296.98 | -177.979 | -118.692 | -81.497 |
| Operating Income Ratio
| -7.913 | -7.94 | 0.527 | 0.255 | -4.416 | -250.322 | -136.742 | -546.96 |
| Total Other Income Expenses Net
| 64.06 | 56.111 | -78.788 | 129.051 | -1.631 | 3.45 | 2.328 | 0.721 |
| Income Before Tax
| -523.105 | -628.194 | 754.28 | 549.802 | -298.611 | -174.529 | -116.364 | -80.776 |
| Income Before Tax Ratio
| -7.049 | -7.289 | 0.477 | 0.506 | -4.441 | -245.47 | -134.06 | -542.121 |
| Income Tax Expense
| -1.145 | -13.077 | 238.443 | 21.218 | 0.054 | 0.154 | -0.48 | -10.924 |
| Net Income
| -521.96 | -615.061 | 515.837 | 528.584 | -298.665 | -174.683 | -115.884 | -69.852 |
| Net Income Ratio
| -7.034 | -7.137 | 0.326 | 0.486 | -4.441 | -245.686 | -133.507 | -468.805 |
| EPS
| -3.83 | -4.59 | 3.89 | 4.07 | -2.51 | -1.62 | -1.2 | -0.72 |
| EPS Diluted
| -3.83 | -4.59 | 3.83 | 3.96 | -2.51 | -1.62 | -1.2 | -0.72 |
| EBITDA
| -537.611 | -664.854 | 833.068 | 420.751 | -289.798 | -173.462 | -115.936 | -81.065 |
| EBITDA Ratio
| -7.245 | -7.715 | 0.597 | 0.26 | -4.416 | -250.322 | -133.567 | -544.06 |